节点文献

γ-干扰素抗肝纤维化临床疗效的初步观察

The primary observation oa the effect of Y-interferon for antifibrosis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 蔡卫民陈智陈峰翁红雷刘荣华

【Author】 Cai Weimin Chen Zhi,Chen Feng et al,The Institute of Infectious Diseases,Zhejiang Medi- cal Univerisyt

【机构】 浙江医科大学附属一院传染病研究所

【摘要】 本文报道用γ-干扰紊(IFN-γ)治疗慢性肝炎肝纤维化20例的结果,另有20例以一般常规治疗为对照。治疗前、后做作肝功能、肝纤维化血清指标(HA、Ⅳ-C、PCⅢ和LN)。治疗后,肝功能均有不同程度好转,尤以白蛋白升高;HA、Ⅳ-CPCⅢ和LN均有明显下降,差异非常显著(P<0.01)。初步证明IFN-γ有一定的抗肝纤维化作用,且无严重副作用。

【Abstract】 Twenty patients with liver fibrosis caused by chronic hepatitis were treated with interferon-Y (IFN-Y). One treatment duration is intramuscular injection 1MU per day for 30 days and 1MU every other day for next 60 days. The liver function and the serum parameters of fibrosis and b Ultrasound all significantly after one or two treatment durtion , while the control group , 20 other similar patients , who were treated with routine treatment had no significant changes. The results showed that IFN-Y has the effect of antifibrosis , and further im proved study is needed.

  • 【文献出处】 临床肝胆病杂志 ,CHINESE JOURNAL OF CLINICAL HEPATOLOGY , 编辑部邮箱 ,1998年01期
  • 【分类号】R575.2
  • 【被引频次】49
  • 【下载频次】77
节点文献中: 

本文链接的文献网络图示:

本文的引文网络